![]() |
市场调查报告书
商品编码
1699337
感染控制个人防护设备市场机会、成长动力、产业趋势分析及 2025-2034 年预测Personal Protective Equipment for Infection Control Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 |
2024 年全球个人防护设备感染控制市场价值为 210 亿美元,预计 2025 年至 2034 年期间的复合年增长率为 3.7%。个人防护设备在减少传染病传播方面发挥关键作用,尤其是在医院、实验室、诊所和工业工作场所等高风险环境中。包括 COVID-19 和流感在内的传染病日益流行,推动了对防护设备的持续需求。此外,抗菌纺织品和人体工学特性的进步提高了 PPE 的舒适性和功能性,促进了市场成长。
2023 年市场价值为 217 亿美元,其中手部和手臂防护设备成为主导领域,占 2024 年收入的 45.2%。医疗相关感染 (HAI) 病例的增加增加了对有效防护装备的需求,特别是具有增强耐用性、触觉灵敏度和耐化学性的手套。由于人们对 PPE 材料的认识不断提高以及技术不断进步,预计该领域在预测期内将经历显着扩张。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 210亿美元 |
预测值 | 294亿美元 |
复合年增长率 | 3.7% |
市场分为一次性 PPE 和可重复使用 PPE,其中一次性 PPE 市场领先,2024 年市场规模达 162 亿美元。由于 CDC 和 WHO 等组织的严格监管建议,一次性 PPE 仍然是医疗机构的首选。医疗保健基础设施的不断扩张进一步刺激了需求,增强了对感染控制用品的必要性。预计减少交叉污染和提高卫生标准的日益重视将推动该领域的成长。
按最终用途划分,医院占据了最大的市场份额,2024 年创造了 126 亿美元的收入。医院优先投资个人防护装备 (PPE),以保护医护人员和病患免受传染威胁。感染控制措施,包括个人防护装备的使用,对于降低医疗机构内疾病传播的风险至关重要。外科手术和医疗程序的不断增加也增加了对高品质防护设备的需求。由于医疗保健提供者继续优先考虑安全性和遵守感染控制协议,预计该领域将在整个预测期内保持稳定成长。
在美国,2024 年感染控制 PPE 市场价值为 88 亿美元,预计到 2034 年将达到 120 亿美元。该国透过 OSHA、CDC 和 FDA 实施严格的感染控制政策,确保在医疗保健环境中遵守 PPE 指南。医院获得性感染发生率的上升进一步推动了对感染控制产品的需求,预计到 2032 年,对这些产品的需求将达到 630 亿美元。强而有力的监管框架,加上对医疗保健安全的重视,将使美国市场在未来几年保持持续成长。
The Global Personal Protective Equipment For Infection Control Market was valued at USD 21 billion in 2024 and is expected to grow at a 3.7% CAGR from 2025 to 2034. PPE plays a critical role in minimizing the spread of infectious diseases, especially in high-risk settings such as hospitals, laboratories, clinics, and industrial workplaces. The continuous demand for protective equipment is driven by the increasing prevalence of infectious diseases, including COVID-19 and influenza. Additionally, advancements in antimicrobial textiles and ergonomic features have enhanced the comfort and functionality of PPE, contributing to market growth.
With the market valued at USD 21.7 billion in 2023, hand and arm protection equipment emerged as the dominant segment, accounting for 45.2% of revenue in 2024. The increasing cases of healthcare-associated infections (HAIs) have heightened the need for effective protective gear, particularly gloves with enhanced durability, tactile sensitivity, and chemical resistance. The segment is anticipated to experience significant expansion over the forecast period due to growing awareness and technological improvements in PPE materials.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $21 Billion |
Forecast Value | $29.4 Billion |
CAGR | 3.7% |
The market is divided into disposable and reusable PPE, with the disposable segment leading at USD 16.2 billion in 2024. Disposable PPE remains a preferred choice in healthcare facilities due to strict regulatory recommendations from organizations such as the CDC and WHO. The demand is further fueled by the continuous expansion of healthcare infrastructure, reinforcing the necessity for infection control supplies. The growing emphasis on reducing cross-contamination and improving hygiene standards is expected to drive the segment's growth.
By end use, hospitals captured the largest market share, generating USD 12.6 billion in revenue in 2024. Hospitals prioritize investment in PPE to safeguard healthcare workers and patients from infectious threats. Infection control measures, including PPE usage, are crucial for reducing the risk of disease transmission in medical facilities. The rising number of surgical and medical procedures also amplifies the demand for high-quality protective equipment. The segment is expected to maintain steady growth throughout the forecast period as healthcare providers continue to prioritize safety and compliance with infection control protocols.
In the United States, the PPE for infection control market was valued at USD 8.8 billion in 2024 and is projected to reach USD 12 billion by 2034. The country enforces strict infection control policies through OSHA, the CDC, and the FDA, ensuring adherence to PPE guidelines in healthcare environments. The rising incidence of HAIs further drives the need for infection control products, with demand for these supplies expected to reach USD 63 billion by 2032. The strong regulatory framework, coupled with the emphasis on healthcare safety, positions the US market for consistent growth in the coming years.